A Study of Safety, PK, & PD of ISIS 416858 Administered Subcutaneously to Patients With End-Stage Renal Disease on Hemodialysis
Clinical trial NCT02553889 · COMPLETED
Trial details
- NCT number
- NCT02553889
- Sponsor
- Ionis Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-10-01
- Primary completion
- 2016-11-01
- Enrollment
- 49
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.